Trial Profile
Bolus versus continuous infusion of piperacillin/tazobactam in patients with ventilator associated pneumonia.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Oct 2011
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Therapeutic Use
- 11 Oct 2011 New trial record
- 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.